Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 184
- Registration Number
- NCT04727190
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2020-12-24
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT04684017
- Locations
- 🇨🇳
Shanghai Chest hospital, Shanghai, Shanghai, China
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
- Conditions
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 450
- Registration Number
- NCT04636047
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 97
- Registration Number
- NCT04613284
Evaluate the Diagnostic Value of BTPNA for PPL: a Real-world Study
Recruiting
- Conditions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT04597346
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Diagnostic Value of UTB and TB for PPL
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 578
- Registration Number
- NCT04571476
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT04507906
- Locations
- 🇨🇳
Shanghai Chest hospital, Shanghai, Shanghai, China
Dacomitinib in Lung Cancer With Uncommon EGFR Mutations
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2022-06-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04504071
- Locations
- 🇨🇳
Shanghai Chest hospital, Shanghai, Shanghai, China
Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image
- Conditions
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 1300
- Registration Number
- NCT04497233
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 1298
- Registration Number
- NCT04489004
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath